TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global AI-based Clinical Trials Solution Provider Market Size, Status and Forecast 2022-2028

Global AI-based Clinical Trials Solution Provider Market Size, Status and Forecast 2022-2028

  • Category:ICT & Media
  • Published on : 03 August 2022
  • Pages :103
  • Formats:
  • Report Code:SMR-7251962
OfferClick for best price

Best Price: $3120

AIbased Clinical Trials Solution Provider Market Size, Share 2022


Market Analysis and Insights: Global AIbased Clinical Trials Solution Provider Market

The global AIbased Clinical Trials Solution Provider market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global AIbased Clinical Trials Solution Provider market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global AIbased Clinical Trials Solution Provider market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global AIbased Clinical Trials Solution Provider market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global AIbased Clinical Trials Solution Provider market.

Global AIbased Clinical Trials Solution Provider Scope and Market Size

This report focuses on the global AI-based Clinical Trials Solution Provider status, future forecast, growth opportunity, key market and key players. The study objectives are to present the AI-based Clinical Trials Solution Provider development in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, etc.

Segment by Type

Segment by Application

  • Pharmaceutical Companies
  • Academia
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

By Company

  • Unlearn.AI, Inc.
  • Saama Technologies
  • Antidote Technologies, Inc.
  • Phesi
  • Deep 6 AI
  • Innoplexus
  • Mendel.ai
  • Intelligencia
  • Median Technologies
  • Symphony AI
  • BioAge Labs, Inc.
  • AiCure, LLC
  • CONSILX
  • DEEP LENS AI
  • Halo Health Systems
  • Pharmaseal
  • Ardigen
  • Trials.Ai
  • Koneksa Health
  • Euretos
  • BioSymetrics
  • Google- Verily
  • GNS Healthcare
  • IBM Watson
  • Exscientia

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes AIbased Clinical Trials Solution Provider product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of AIbased Clinical Trials Solution Provider, with price, sales, revenue, and global market share of AIbased Clinical Trials Solution Provider from 2019 to 2022.

Chapter 3, the AIbased Clinical Trials Solution Provider competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the AIbased Clinical Trials Solution Provider breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the AIbased Clinical Trials Solution Provider market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of AIbased Clinical Trials Solution Provider.

Chapter 13, 14, and 15, to describe AIbased Clinical Trials Solution Provider sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 AIbased Clinical Trials Solution Provider Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global AI-based Clinical Trials Solution Provider Market Size, Status and Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 103 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-based Clinical Trials Solution Provider Market Size Growth Rate by Type (2022-2028)
1.2.2 Phase-I
1.2.3 Phase-II
1.2.4 Phase-III
1.3 Market by Application
1.3.1 Global AI-based Clinical Trials Solution Provider Market Share by Application (2022-2028)
1.3.2 Pharmaceutical Companies
1.3.3 Academia
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global AI-based Clinical Trials Solution Provider Market Size
2.2 AI-based Clinical Trials Solution Provider Market Size by Regions
2.2.1 AI-based Clinical Trials Solution Provider Growth Rate by Regions (2022-2028)
2.2.2 AI-based Clinical Trials Solution Provider Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 AI-based Clinical Trials Solution Provider Revenue by Players (2022 & 2028)
3.2 AI-based Clinical Trials Solution Provider Key Players Headquarters and Area Served
3.3 Key Players AI-based Clinical Trials Solution Provider Product/Solution/Service
3.4 Date of Enter into AI-based Clinical Trials Solution Provider Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global AI-based Clinical Trials Solution Provider Market Size by Type (2022-2028)
4.2 Global AI-based Clinical Trials Solution Provider Market Size by Application (2022-2028)
5 North America
5.1 North America AI-based Clinical Trials Solution Provider Market Forecast (2022-2028)
5.2 AI-based Clinical Trials Solution Provider Key Players in North America
5.3 North America AI-based Clinical Trials Solution Provider Market Size by Type
5.4 North America AI-based Clinical Trials Solution Provider Market Size by Application
6 Europe
6.1 Europe AI-based Clinical Trials Solution Provider Market Forecast (2022-2028)
6.2 AI-based Clinical Trials Solution Provider Key Players in Europe
6.3 Europe AI-based Clinical Trials Solution Provider Market Size by Type
6.4 Europe AI-based Clinical Trials Solution Provider Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific AI-based Clinical Trials Solution Provider Market Forecast (2022-2028)
7.2 AI-based Clinical Trials Solution Provider Key Players in Asia-Pacific
7.3 Asia-Pacific AI-based Clinical Trials Solution Provider Market Size by Type
7.4 Asia-Pacific AI-based Clinical Trials Solution Provider Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America AI-based Clinical Trials Solution Provider Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa AI-based Clinical Trials Solution Provider Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
9.1 Unlearn.AI, Inc.
9.1.1 Unlearn.AI, Inc. Company Details
9.1.2 Unlearn.AI, Inc. Description and Business Overview
9.1.3 Unlearn.AI, Inc. AI-based Clinical Trials Solution Provider Introduction
9.1.4 Unlearn.AI, Inc. Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.1.5 Unlearn.AI, Inc. Recent Development
9.2 Saama Technologies
9.2.1 Saama Technologies Company Details
9.2.2 Saama Technologies Description and Business Overview
9.2.3 Saama Technologies AI-based Clinical Trials Solution Provider Introduction
9.2.4 Saama Technologies Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.2.5 Saama Technologies Recent Development
9.3 Antidote Technologies, Inc.
9.3.1 Antidote Technologies, Inc. Company Details
9.3.2 Antidote Technologies, Inc. Description and Business Overview
9.3.3 Antidote Technologies, Inc. AI-based Clinical Trials Solution Provider Introduction
9.3.4 Antidote Technologies, Inc. Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.3.5 Antidote Technologies, Inc. Recent Development
9.4 Phesi
9.4.1 Phesi Company Details
9.4.2 Phesi Description and Business Overview
9.4.3 Phesi AI-based Clinical Trials Solution Provider Introduction
9.4.4 Phesi Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.4.5 Phesi Recent Development
9.5 Deep 6 AI
9.5.1 Deep 6 AI Company Details
9.5.2 Deep 6 AI Description and Business Overview
9.5.3 Deep 6 AI AI-based Clinical Trials Solution Provider Introduction
9.5.4 Deep 6 AI Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.5.5 Deep 6 AI Recent Development
9.6 Innoplexus
9.6.1 Innoplexus Company Details
9.6.2 Innoplexus Description and Business Overview
9.6.3 Innoplexus AI-based Clinical Trials Solution Provider Introduction
9.6.4 Innoplexus Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.6.5 Innoplexus Recent Development
9.7 Mendel.ai
9.7.1 Mendel.ai Company Details
9.7.2 Mendel.ai Description and Business Overview
9.7.3 Mendel.ai AI-based Clinical Trials Solution Provider Introduction
9.7.4 Mendel.ai Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.7.5 Mendel.ai Recent Development
9.8 Intelligencia
9.8.1 Intelligencia Company Details
9.8.2 Intelligencia Description and Business Overview
9.8.3 Intelligencia AI-based Clinical Trials Solution Provider Introduction
9.8.4 Intelligencia Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.8.5 Intelligencia Recent Development
9.9 Median Technologies
9.9.1 Median Technologies Company Details
9.9.2 Median Technologies Description and Business Overview
9.9.3 Median Technologies AI-based Clinical Trials Solution Provider Introduction
9.9.4 Median Technologies Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.9.5 Median Technologies Recent Development
9.10 Symphony AI
9.10.1 Symphony AI Company Details
9.10.2 Symphony AI Description and Business Overview
9.10.3 Symphony AI AI-based Clinical Trials Solution Provider Introduction
9.10.4 Symphony AI Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.10.5 Symphony AI Recent Development
9.11 BioAge Labs, Inc.
9.11.1 BioAge Labs, Inc. Company Details
9.11.2 BioAge Labs, Inc. Description and Business Overview
9.11.3 BioAge Labs, Inc. AI-based Clinical Trials Solution Provider Introduction
9.11.4 BioAge Labs, Inc. Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.11.5 BioAge Labs, Inc. Recent Development
9.12 AiCure, LLC
9.12.1 AiCure, LLC Company Details
9.12.2 AiCure, LLC Description and Business Overview
9.12.3 AiCure, LLC AI-based Clinical Trials Solution Provider Introduction
9.12.4 AiCure, LLC Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.12.5 AiCure, LLC Recent Development
9.13 CONSILX
9.13.1 CONSILX Company Details
9.13.2 CONSILX Description and Business Overview
9.13.3 CONSILX AI-based Clinical Trials Solution Provider Introduction
9.13.4 CONSILX Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.13.5 CONSILX Recent Development
9.14 DEEP LENS AI
9.14.1 DEEP LENS AI Company Details
9.14.2 DEEP LENS AI Description and Business Overview
9.14.3 DEEP LENS AI AI-based Clinical Trials Solution Provider Introduction
9.14.4 DEEP LENS AI Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.14.5 DEEP LENS AI Recent Development
9.15 Halo Health Systems
9.15.1 Halo Health Systems Company Details
9.15.2 Halo Health Systems Description and Business Overview
9.15.3 Halo Health Systems AI-based Clinical Trials Solution Provider Introduction
9.15.4 Halo Health Systems Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.15.5 Halo Health Systems Recent Development
9.16 Pharmaseal
9.16.1 Company Details
9.16.2 Pharmaseal Description and Business Overview
9.16.3 Pharmaseal AI-based Clinical Trials Solution Provider Introduction
9.16.4 Pharmaseal Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.16.5 Pharmaseal Recent Development
9.17 Ardigen
9.17.1 Ardigen Company Details
9.17.2 Ardigen Description and Business Overview
9.17.3 Ardigen AI-based Clinical Trials Solution Provider Introduction
9.17.4 Ardigen Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.17.5 Ardigen Recent Development
9.18 Trials.Ai
9.18.1 Trials.Ai Company Details
9.18.2 Trials.Ai Description and Business Overview
9.18.3 Trials.Ai AI-based Clinical Trials Solution Provider Introduction
9.18.4 Trials.Ai Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.18.5 Trials.Ai Recent Development
9.19 Koneksa Health
9.19.1 Koneksa Health Company Details
9.19.2 Koneksa Health Description and Business Overview
9.19.3 Koneksa Health AI-based Clinical Trials Solution Provider Introduction
9.19.4 Koneksa Health Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.19.5 Koneksa Health Recent Development
9.20 Euretos
9.20.1 Euretos Company Details
9.20.2 Euretos Description and Business Overview
9.20.3 Euretos AI-based Clinical Trials Solution Provider Introduction
9.20.4 Euretos Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.20.5 Euretos Recent Development
9.21 BioSymetrics
9.21.1 BioSymetrics Company Details
9.21.2 BioSymetrics Description and Business Overview
9.21.3 BioSymetrics AI-based Clinical Trials Solution Provider Introduction
9.21.4 BioSymetrics Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.21.5 BioSymetrics Recent Development
9.22 Google- Verily
9.22.1 Google- Verily Company Details
9.22.2 Google- Verily Description and Business Overview
9.22.3 Google- Verily AI-based Clinical Trials Solution Provider Introduction
9.22.4 Google- Verily Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.22.5 Google- Verily Recent Development
9.23 GNS Healthcare
9.23.1 GNS Healthcare Company Details
9.23.2 GNS Healthcare Description and Business Overview
9.23.3 GNS Healthcare AI-based Clinical Trials Solution Provider Introduction
9.23.4 GNS Healthcare Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.23.5 GNS Healthcare Recent Development
9.24 IBM Watson
9.24.1 IBM Watson Company Details
9.24.2 IBM Watson Description and Business Overview
9.24.3 IBM Watson AI-based Clinical Trials Solution Provider Introduction
9.24.4 IBM Watson Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.24.5 IBM Watson Recent Development
9.25 Exscientia
9.25.1 Exscientia Company Details
9.25.2 Exscientia Description and Business Overview
9.25.3 Exscientia AI-based Clinical Trials Solution Provider Introduction
9.25.4 Exscientia Revenue in AI-based Clinical Trials Solution Provider Business (2022 & 2028)
9.25.5 Exscientia Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global AI-based Clinical Trials Solution Provider Market Size Growth Rate by Type (2022-2028) (US$ Million)
Table 2. Key Players of Phase-I
Table 3. Key Players of Phase-II
Table 4. Key Players of Phase-III
Table 5. Global AI-based Clinical Trials Solution Provider Market Size Growth by Application (2022-2028) (US$ Million)
Table 6. Global AI-based Clinical Trials Solution Provider Market Size by Regions (2022-2028) (US$ Million)
Table 7. Global AI-based Clinical Trials Solution Provider Market Share by Regions (2022-2028)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global AI-based Clinical Trials Solution Provider Revenue by Players (2022 & 2028) (US$ Million)
Table 11. Global AI-based Clinical Trials Solution Provider Market Share by Players (2022 &2028)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players AI-based Clinical Trials Solution Provider Product/Solution/Service
Table 14. Date of Enter into AI-based Clinical Trials Solution Provider Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global AI-based Clinical Trials Solution Provider Market Size by Type (2022-2028) (US$ Million)
Table 17. Global AI-based Clinical Trials Solution Provider Market Size Share by Type (2022-2028)
Table 18. Global AI-based Clinical Trials Solution Provider Market Size by Application (2022-2028) (US$ Million)
Table 19. Global AI-based Clinical Trials Solution Provider Market Size Share by Application (2022-2028)
Table 20. North America Key Players AI-based Clinical Trials Solution Provider Revenue (2022 & 2028) & (US$ Million)
Table 21. North America Key Players AI-based Clinical Trials Solution Provider Market Share (2022 & 2028)
Table 22. North America AI-based Clinical Trials Solution Provider Market Size by Type (2022-2028) (US$ Million)
Table 23. North America AI-based Clinical Trials Solution Provider Market Share by Type (2022-2028)
Table 24. North America AI-based Clinical Trials Solution Provider Market Size by Application (2022-2028) (US$ Million)
Table 25. North America AI-based Clinical Trials Solution Provider Market Share by Application (2022-2028)
Table 26. Europe Key Players AI-based Clinical Trials Solution Provider Revenue (2022 & 2028) & (US$ Million)
Table 27. Europe Key Players AI-based Clinical Trials Solution Provider Market Share (2022 & 2028)
Table 28. Europe AI-based Clinical Trials Solution Provider Market Size by Type (2022-2028) (US$ Million)
Table 29. Europe AI-based Clinical Trials Solution Provider Market Share by Type (2022-2028)
Table 30. Europe AI-based Clinical Trials Solution Provider Market Size by Application (2022-2028) (US$ Million)
Table 31. Europe AI-based Clinical Trials Solution Provider Market Share by Application (2022-2028)
Table 32. Asia-Pacific Key Players AI-based Clinical Trials Solution Provider Revenue (2022 & 2028) & (US$ Million)
Table 33. Asia-Pacific Key Players AI-based Clinical Trials Solution Provider Market Share (2022 & 2028)
Table 34. Asia-Pacific AI-based Clinical Trials Solution Provider Market Size by Type (2022-2028) (US$ Million)
Table 35. Asia-Pacific AI-based Clinical Trials Solution Provider Market Share by Type (2022-2028)
Table 36. Asia-Pacific AI-based Clinical Trials Solution Provider Market Size by Application (2022-2028) (US$ Million)
Table 37. Asia-Pacific AI-based Clinical Trials Solution Provider Market Share by Application (2022-2028)
Table 38. Key Players in Latin America
Table 39. Key Players in Middle East & Africa
Table 40. Unlearn.AI, Inc. Company Details
Table 41. Unlearn.AI, Inc. Description and Business Overview
Table 42. Unlearn.AI, Inc. AI-based Clinical Trials Solution Provider Product
Table 43. Unlearn.AI, Inc. Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 44. Unlearn.AI, Inc. Recent Development
Table 45. Saama Technologies Company Details
Table 46. Saama Technologies Description and Business Overview
Table 47. Saama Technologies AI-based Clinical Trials Solution Provider Product
Table 48. Saama Technologies Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 49. Saama Technologies Recent Development
Table 50. Antidote Technologies, Inc. Company Details
Table 51. Antidote Technologies, Inc. Description and Business Overview
Table 52. Antidote Technologies, Inc. AI-based Clinical Trials Solution Provider Product
Table 53. Antidote Technologies, Inc. Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 54. Antidote Technologies, Inc. Recent Development
Table 55. Phesi Company Details
Table 56. Phesi Description and Business Overview
Table 57. Phesi AI-based Clinical Trials Solution Provider Product
Table 58. Phesi Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 59. Phesi Recent Development
Table 60. Deep 6 AI Company Details
Table 61. Deep 6 AI Description and Business Overview
Table 62. Deep 6 AI AI-based Clinical Trials Solution Provider Product
Table 63. Deep 6 AI Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 64. Deep 6 AI Recent Development
Table 65. Innoplexus Company Details
Table 66. Innoplexus Description and Business Overview
Table 67. Innoplexus AI-based Clinical Trials Solution Provider Product
Table 68. Innoplexus Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 69. Innoplexus Recent Development
Table 70. Mendel.ai Company Details
Table 71. Mendel.ai Description and Business Overview
Table 72. Mendel.ai AI-based Clinical Trials Solution Provider Product
Table 73. Mendel.ai Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 74. Mendel.ai Recent Development
Table 75. Intelligencia Company Details
Table 76. Intelligencia Description and Business Overview
Table 77. Intelligencia AI-based Clinical Trials Solution Provider Product
Table 78. Intelligencia Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 79. Intelligencia Recent Development
Table 80. Median Technologies Company Details
Table 81. Median Technologies Description and Business Overview
Table 82. Median Technologies AI-based Clinical Trials Solution Provider Product
Table 83. Median Technologies Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 84. Median Technologies Recent Development
Table 85. Symphony AI Company Details
Table 86. Symphony AI Description and Business Overview
Table 87. Symphony AI AI-based Clinical Trials Solution Provider Product
Table 88. Symphony AI Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 89. Symphony AI Recent Development
Table 90. BioAge Labs, Inc. Company Details
Table 91. BioAge Labs, Inc. Description and Business Overview
Table 92. BioAge Labs, Inc. AI-based Clinical Trials Solution Provider Product
Table 93. BioAge Labs, Inc. Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 94. BioAge Labs, Inc. Recent Development
Table 95. AiCure, LLC Company Details
Table 96. AiCure, LLC Description and Business Overview
Table 97. AiCure, LLC AI-based Clinical Trials Solution Provider Product
Table 98. AiCure, LLC Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 99. AiCure, LLC Recent Development
Table 100. CONSILX Company Details
Table 101. CONSILX Description and Business Overview
Table 102. CONSILX AI-based Clinical Trials Solution Provider Product
Table 103. CONSILX Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 104. CONSILX Recent Development
Table 105. DEEP LENS AI Company Details
Table 106. DEEP LENS AI Description and Business Overview
Table 107. DEEP LENS AI AI-based Clinical Trials Solution Provider Product
Table 108. DEEP LENS AI Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 109. DEEP LENS AI Recent Development
Table 110. Halo Health Systems Company Details
Table 111. Halo Health Systems Description and Business Overview
Table 112. Halo Health Systems AI-based Clinical Trials Solution Provider Product
Table 113. Halo Health Systems Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 114. Halo Health Systems Recent Development
Table 115. Pharmaseal Company Details
Table 116. Pharmaseal Description and Business Overview
Table 117. Pharmaseal AI-based Clinical Trials Solution Provider Product
Table 118. Pharmaseal Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 119. Pharmaseal Recent Development
Table 120. Ardigen Company Details
Table 121. Ardigen Description and Business Overview
Table 122. Ardigen AI-based Clinical Trials Solution Provider Product
Table 123. Ardigen Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 124. Ardigen Recent Development
Table 125. Trials.Ai Company Details
Table 126. Trials.Ai Description and Business Overview
Table 127. Trials.Ai AI-based Clinical Trials Solution Provider Product
Table 128. Trials.Ai Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 129. Trials.Ai Recent Development
Table 130. Koneksa Health Company Details
Table 131. Koneksa Health Description and Business Overview
Table 132. Koneksa Health AI-based Clinical Trials Solution Provider Product
Table 133. Koneksa Health Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 134. Koneksa Health Recent Development
Table 135. Euretos Company Details
Table 136. Euretos Description and Business Overview
Table 137. Euretos AI-based Clinical Trials Solution Provider Product
Table 138. Euretos Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 139. Euretos Recent Development
Table 140. BioSymetrics Company Details
Table 141. BioSymetrics Description and Business Overview
Table 142. BioSymetrics AI-based Clinical Trials Solution Provider Product
Table 143. BioSymetrics Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 144. BioSymetrics Recent Development
Table 145. Google- Verily Company Details
Table 146. Google- Verily Description and Business Overview
Table 147. Google- Verily AI-based Clinical Trials Solution Provider Product
Table 148. Google- Verily Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 149. Google- Verily Recent Development
Table 150. GNS Healthcare Company Details
Table 151. GNS Healthcare Description and Business Overview
Table 152. GNS Healthcare AI-based Clinical Trials Solution Provider Product
Table 153. GNS Healthcare Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 154. GNS Healthcare Recent Development
Table 155. IBM Watson Company Details
Table 156. IBM Watson Description and Business Overview
Table 157. IBM Watson AI-based Clinical Trials Solution ProviderProduct
Table 158. IBM Watson Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 159. IBM Watson Recent Development
Table 160. Exscientia Company Details
Table 161. Exscientia Description and Business Overview
Table 162. Exscientia AI-based Clinical Trials Solution Provider Product
Table 163. Exscientia Revenue in AI-based Clinical Trials Solution Provider Business 2022 & 2028
Table 164. Exscientia Recent Development
Table 165. AI-based Clinical Trials Solution Provider Market Trends
Table 166. AI-based Clinical Trials Solution Provider Market Drivers
Table 167. AI-based Clinical Trials Solution Provider Market Challenges
Table 168. AI-based Clinical Trials Solution Provider Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AI-based Clinical Trials Solution Provider Market Share by Type in 2022 & 2028
Figure 2. Phase-I Features
Figure 3. Phase-II Features
Figure 4. Phase-III Features
Figure 5. Global AI-based Clinical Trials Solution Provider Market Share by Application in 2022 & 2028
Figure 6. Pharmaceutical Companies Case Studies
Figure 7. Academia Case Studies
Figure 8. Others Case Studies
Figure 9. AI-based Clinical Trials Solution Provider Report Years Considered
Figure 10. Global AI-based Clinical Trials Solution Provider Market Size and Growth Rate (2022-2028) (US$ Million)
Figure 11. Global AI-based Clinical Trials Solution Provider Market Share by Regions (2022-2028)
Figure 12. Global AI-based Clinical Trials Solution Provider Market Share by Players in 2021
Figure 13. Global AI-based Clinical Trials Solution Provider Market Size Market Share by Type (2022-2028)
Figure 14. Global AI-based Clinical Trials Solution Provider Market Size Market Share by Application (2022-2028)
Figure 15. Global AI-based Clinical Trials Solution Provider Revenue Market Share by Application in 2021
Figure 16. North America AI-based Clinical Trials Solution Provider Market Size 2022-2028 (US$ Million)
Figure 17. Europe AI-based Clinical Trials Solution Provider Market Size 2022-2028 (US$ Million)
Figure 18. Asia-Pacific AI-based Clinical Trials Solution Provider Market Size 2022-2028 (US$ Million)
Figure 19. AI-based Clinical Trials Solution Provider Market Size in Latin America (2022-2028) (US$ Million)
Figure 20. AI-based Clinical Trials Solution Provider Market Size in Middle East & Africa (2022-2028) (US$ Million)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount